Category: NewsThis is the default category for all posts – these are seen as “News” items.
This is the default category for all posts – these are seen as “News” items.
Ground-breaking OWise mobile app for prostate cancer patients launched in the UK today
The new OWise app has been co-designed with prostate cancer patients to support them with their treatment and life after diagnosis.
The future of healthcare is through apps: A Siemens Healthineers Analysis
The team at Economist Intelligence Unit (EIU) has explored how digitalisation has impacted patient care. Find out how OWise can improve cancer care and how to integrate it into your hospital.
Digital health apps to transform cancer and dementia care
OWise for prostate cancer is currently under development. Read here to see OWise’s feature in The Herald and how the app hopes to benefit prostate cancer patients.
NHS Lothian trials groundbreaking OWise cancer patient app
A version of OWise that is integrated into the hospital’s electronic health record system is being trialled at NHS Lothian in Scotland. Read here to see OWise’s feature in The National about this, and how it is benefitting patients and clinicians.
OWise breast cancer listed in the Top 25 of all health apps by IQVIA.
OWise breast cancer was listed in the Top 25 of all health apps by IQVIA.
First place in the Digital Health Masterclass Challenge 2013
Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.
NHS Innovation Accelerator
Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands to develop OWise in 2015. The NIA is facilitating Anne’s … Continue reading “NHS Innovation Accelerator”
OWise receives top prize in Scotland’s Cancer Innovation Challenge
OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!
OWise wins top NESTA Healthier Lives Data Fund Prize
Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland.
Evaluating mobile applications for Breast Cancer in Germany: A systematic review
A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.
CE-marked: Class I Medical Device
OWise was CE-marked to comply with the European regulatory standards for safety and usage on the 7th of May, 2014.
NHS approved
OWise is one in five cancer apps listed in the NHS app library.